Medicines (incl anaesthetics and inhalers)

Technical Case Study Globally,anaesthetic gases are responsible for ∼2-3% of Healthcare’s carbon footprint.The United Kingdom has steadfastly reduced its emissions associated with volatile…

Technical Case Study Populations are ageing and many people over the age of 50 years live with multiplelong-term conditions and as a result take multiple medications (known aspolypharmacy).…

Technical Case Study Propellant gases contained in metered dose inhalers are powerful greenhouse gases and approximately 3% of the carbon footprint of NHS Scotland results from these inhalers.…

Pharmacists for Greener Healthcare are hosting two online workshops on 27 November and 19 December. Don’t miss this chance to connect with fellow members and learn from leading experts about…

Propellants in metered dose inhalers are powerful greenhouse gases. It is five years since the Climate Change Act (2008) was introduced to ensure that by 2050 the United Kingdom cuts its carbon…

This study explores the economic cost and carbon footprint associated with current patterns of prescribing long-term flupentixol decanoate long-acting injections. Authors conducted an analysis of…

The targets of the Climate Change Act are very challenging for the NHS, which means fundamental transformation of clinical practices will be required to meet them.Sustainability in the NHS has mostly…

Abstract Background In-hospital promotion of the oral route and IV to oral switch (IVOST)1are key antimicrobial stewardship (AS) initiatives providing benefits for patients, staff and the…

Combatting antimicrobial resistance – theUK second five-year national action plancontinues to promote optimal use of antimicrobials in humans to ensure safe and effective patient care by strengthening…

Abstract - beware carbon values not included Aims Healthcare accounts for 5% of global greenhouse gas emissions, with medicines making a sizeable contribution. Product-level medicine emission…